Cargando…

Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer

OBJECTIVE: We retrospectively investigated the prognostic significance of the pretreatment prognostic nutritional index (PNI) in patients with epithelial ovarian cancer (EOC) according to the clinical stage. METHODS: The baseline characteristics and clinical outcomes of 308 EOC patients were collect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komura, Naoko, Mabuchi, Seiji, Yokoi, Eriko, Shimura, Kotaro, Kawano, Mahiru, Matsumoto, Yuri, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557203/ https://www.ncbi.nlm.nih.gov/pubmed/31217896 http://dx.doi.org/10.18632/oncotarget.26914

Ejemplares similares

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
por: Shimura, Kotaro, et al.
Publicado: (2021)

Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies
por: Mabuchi, Seiji, et al.
Publicado: (2020)

Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017)

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
por: Kuroda, Hiromasa, et al.
Publicado: (2018)

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models
por: Kozasa, Katsumi, et al.
Publicado: (2019)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015)

Prognostic significance of tumor laterality in advanced ovarian cancer
por: Yamada, Yuki, et al.
Publicado: (2021)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
por: Yokoi, Eriko, et al.
Publicado: (2017)

Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
por: Matsuo, Koji, et al.
Publicado: (2015)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy
por: Mabuchi, Seiji, et al.
Publicado: (2022)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Prognostic Impact of Pretreatment Thrombocytosis in Epithelial Ovarian Cancer
por: Okunade, KS, et al.
Publicado: (2020)

Significance of lymphovascular space invasion in epithelial ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2012)

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2018)

Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
por: Dobrzycka, Bozena, et al.
Publicado: (2015)

Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: A systematic review and meta-analysis
por: Dai, Yan, et al.
Publicado: (2020)

Prognostic significance of pretreatment controlling nutritional status score in urological cancers: a systematic review and meta‐analysis
por: Niu, Xinhao, et al.
Publicado: (2021)

Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer
por: Okunade, Kehinde S, et al.
Publicado: (2023)

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
por: Deng, Yan, et al.
Publicado: (2016)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis
por: Mao, Changqing, et al.
Publicado: (2021)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
por: Chen, Ying, et al.
Publicado: (2015)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
por: Isobe, Aki, et al.
Publicado: (2015)

The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer
por: Shibutani, Masatsune, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
por: Mori, Shunsuke, et al.
Publicado: (2015)

Prognostic significance of pretreatment serum lactate dehydrogenase-to-albumin ratio in gastric cancer
por: Aday, Ulaş, et al.
Publicado: (2020)

Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas
por: Hachisuga, Toru, et al.
Publicado: (2022)

The role of pretreatment prognostic nutritional index in esophageal cancer: A meta‐analysis
por: Xue, Yibo, et al.
Publicado: (2019)

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011)

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
por: Berntsson, Jonna, et al.
Publicado: (2014)

Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
por: Kim, So Young, et al.
Publicado: (2019)

Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis
por: Luan, Chih-Wei, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis
por: Bai, Yi-Yang, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis
por: Chen, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hbpkkjan4vd0r1cmpdqmmee2qa